Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc

Bullboard Posts

Post by logical1234on Dec 18, 2001 3:36pm

1854 Views

Post# 4538023

ONC as business people

Most of these guys are doctors, not financial sharks. Even Schnarr is a Dr. Do you think we can count on them swinging an amazing deal for SYB? They seem more involved with the science of the product than maximizing shareholder value and share prices. And who could they get to help them? Their previous financial advisors were Canaccord and Merrill -- they're not a good idea.

Bullboard Posts

Gold Flora's Gramlin holds court in California cannabis market